Safety and efficacy of transplantation of nurown (autologous mesenchymal stromal cells secreting neurotrophic factors) in patients with ALS: A phase 2 randomized double blind placebo controlled trial

• DOI: 10.1016/j.jcyt.2017.02.040
• Publication Date: 2017-05-01T12:18:03Z
• Authors: Y. Gothelf; M. Cudkowicz; J. Berry; A. Windebank; N. Staff; M. Owegi; Y.S. Levy; R. Aricha; M. Mehra; C. Lebovits; R. Brown
• Keywords: 0502 economics and business; 05 social sciences